Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
EasyGym operates an international, low-cost, fast-growing, big-box gym franchise network. While working with 6 countries and more than 250 sites, easyGym is growing rapidly with its franchise system and cloud-based technology. It is aiming to provide people with access to high-quality gyms that are open 24/7. The company aims to use its recurring revenue to develop a sustainable business platform capable to drive innovation, generate investment value, and support global expansion. With the proceeds, easyGym will build the biggest global fitness network by 2030. 50% of its proceeds will be used to create a corporate hub in London, 17% will be used in Franchise Marketing, and 33% will be used for Technology and Support.
days to go:
Expired
investment:
£828,357
White Peak Distillery (WPD) is a whisky distillery that aims to change the way whisky is made and create authentic flavours. It has so far invested £1.4 million in tried and tested plant equipment producing 400,000 bottles of maturing whisky. The company aims to become a contender in the $60 billion global premium whisky market. WPD has received 'Gold Awards' from The Wizards of Whisky World Whisky Awards. It has come out with programs to monetise its maturing whisky including its Cask Sales program, Temperance Club membership and its Prologue 2.1 release 2-year aged single malt spirit, that has been received with positive feedback. WPD has also been awarded visitor business in The Peak District, which receives 13 million+ visitors per annum, boosting its Direct-to-Consumer (D2C) model. It will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£1,301,320
Sauce Shop is a craft condiment brand which offers customers a variety of fresh-tasting, innovative and punchy flavoured sauces. The company's products have received 2000 5-star reviews on their online shop, and total revenue is over £340k (EBITDA -£13.5k - July 2019). The revenue growth of the company is over 100% YOY. The brand is now stocked in Sainsbury's, Harvey Nichols, Whole Foods Market and many independent food retailers across the UK. Its Tomato Ketchup won a 2-star Great Taste Award. The company will use the funds to expand operational capacity, grow its team and to facilitate a move in premises to ensure that they can continue to meet demand.
days to go:
Expired
investment:
£254,270
Troubadour is a London-based menswear brand specialising in designing minimalist bags & accessories by combining performance design with a clean & modern aesthetic feel. The company has delivered its products to 60+ wholesalers. It is backed by Pembroke VCT, a luxury-focused venture capital firm based in London. Troubadour is planning to work with non-traditional retailers including Ritz Carlton, Four Seasons, and Equinox. It has also collaborated with many world-renowned brands such as British tailors 'Thom Sweeney' and British essentials brand 'Sunspel' that is famous for clothing James Bond. The company has also been a case study for classes at the Harvard Business School. With the investment, the company will support sales growth to its customers and retail partners and also fund working capital requirements from its forecast growth plan.
days to go:
Expired
investment:
£621,240
Milbotix, a healthtech start-up, supported by the Alzheimer's Society and the UK Dementia Research Institute, is driven by its innovative product SmartSocks™. This wearable technology aims to assist individuals with dementia facing communication challenges and their caregivers. Globally, the number of people with dementia is increasing significantly, reaching 78 million by 2030 and 139 million by 2050. Half of those diagnosed with dementia encounter challenging behavioral symptoms due to distress. Early distress management not only enhances well-being but also helps prevent escalating behavioral issues. SmartSocks™ utilize sensors and artificial intelligence to notify dementia caregivers about early signs of pain and anxiety in their patients.
days to go:
Expired
investment:
£220,780
Loupe London is a jewellery company that aims to join London’s £42 billion-a-year creative industries market and set a new benchmark into the art of jewellery making. It plans to create an experiential destination in the heart of London’s heritage-rich 'Jewellery Quarter', and connect UK artisans and discerning consumers who share an appreciation for craft, creativity, and unique design. Loupe's team strives to celebrate UK's famous 'Hatton Garden' heritage, protect artisan skills by offering business support, and establish a workspace for artisans and future talent to build their careers. The company estimates that 80% of consumers prefer independent brands, are mindful of sustainable purchases and attracted to 'Made in UK' products. Loupe aims to target this cater to this segment. The company will use the investment to build creative utilitarian immersive space and a website with integrated social channels.
days to go:
Expired
investment:
£77,738
